Pharmaceutical manufacturers of Hydroxypropyl beta cyclodextrin

ROQUETTE is dedicated to providing the finest from natural sources. It stands as a worldwide frontrunner in plant-derived components, an innovator in plant-derived proteins, and a top supplier of medical excipients. By working alongside its clients and associates, the organization tackles present and future societal obstacles by harnessing the capabilities of nature to present superior ingredients for the food, nutrition, and health sectors. These components satisfy distinct and vital requirements, promote healthier ways of living, and are essential elements of life-preserving medications.

Cyclo Therapeutics, Inc. (formerly known as CTD Holdings, Inc.) was established as a Florida-based company on August 9, 1990, and commenced its operations in July 1992. As part of a reorganization in 2000, the company rebranded from Cyclodextrin Technologies Development, Inc. (CTDI) to CTD Holdings, Inc. CTDI was subsequently established as a Florida corporation and became a wholly owned subsidiary of CTD Holdings, Inc. It is a biotechnology company in the clinical stage, specializing in the utilization of cyclodextrins in pharmaceutical research and development.

Zibo Qianhui Biological Technology Co., Ltd operates as a pharmaceutical excipient company involved in the areas of exploration, production, and commerce. Established in 2006, Qianhui is distinguished as the leading firm specializing in the exploration and production of Cyclodextrin and its derivatives within China. The company's primary offerings include Hydroxypropyl Beta Cyclodextrin, Sulfobutyl Ether Beta Cyclodextrin Sodium, Hydroxypropyl (Sulfobutyl Ether) Gamma Cyclodextrin, Methyl Beta Cyclodextrin, Carboxymethyl Beta Cyclodextrin, Hydroxyethyl Beta Cyclodextrin, Piroxicam Beta Cyclodextrin, and more.